Free Trial

Akso Health Group (NASDAQ:AHG) Receives Sell (D-) Rating from Weiss Ratings

Akso Health Group logo with Retail/Wholesale background

Key Points

  • Akso Health Group's stock has been reaffirmed with a "sell (D-)" rating by Weiss Ratings.
  • The stock traded at $1.71, with a one-year trading range between $0.74 and $2.35.
  • Akso Health Group operates a social e-commerce mobile platform in China, specifically the Xiaobai Maimai App, which sells a variety of consumer products.
  • Interested in Akso Health Group? Here are five stocks we like better.

Akso Health Group (NASDAQ:AHG - Get Free Report)'s stock had its "sell (d-)" rating reaffirmed by investment analysts at Weiss Ratings in a report issued on Friday,Weiss Ratings reports.

Akso Health Group Stock Performance

Shares of NASDAQ:AHG traded up $0.03 during midday trading on Friday, hitting $1.71. 638 shares of the stock traded hands, compared to its average volume of 29,958. Akso Health Group has a one year low of $0.74 and a one year high of $2.35. The business's 50 day moving average is $1.73 and its two-hundred day moving average is $1.56.

About Akso Health Group

(Get Free Report)

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Akso Health Group Right Now?

Before you consider Akso Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Akso Health Group wasn't on the list.

While Akso Health Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.